The economy may be rebounding, but we will be ‘paying’ for the government’s pandemic spending for years to come. Clarify your understanding of where the U.S. stands in comparison to Canada with respect to drug pricing and ‘profit-taking.’ Gain insight into similarities you may not be aware of, and bring back learnings to:
- Re-evaluate your assumptions when it comes to price setting.
- Reassess your current plans for 2022.
- Improve your chances of success when drafting PLAs.
Maximize the potential of your U.S. dealings with an in-depth understanding of the current state of play.